Successful Management of Anti-mGluR1 Encephalitis with Immunosuppressive Treatment: Dengue Virus as a Trigger?

Mov Disord Clin Pract. 2019 Oct 23;6(8):727-728. doi: 10.1002/mdc3.12841. eCollection 2019 Nov.

Hugo Chaumont^{1

2

3}, Aimée Petit^{4

5

6}, Tanicia Mameri^{1

2}, Romain Schollhammer^{2

7}, Jérome Honnorat^{8

9}, Annie Lannuzel^{1

2

3}

¹ Department of Neurology University Hospital of Guadeloupe Pointe-à-Pitre France.
² French West Indies Faculty of Medicine, French West Indies Pointe-à-Pitre France.
³ Sorbonne University, Faculty of Medicine, National Institute of Health and Medical Research, U 1127, CNRS, Joint Research Unit 7225, Institute of Brain and Spinal Cord, ICM Paris France.
⁴ Department of Neurology, APHP, Henri Mondor Hospital Créteil France.
⁵ Faculty of Medicine, Paris Est University Créteil France.
⁶ INSERM U955 team E01, Interventional Neuropsychology Créteil France.
⁷ Department of Nuclear Medicine, University Hospital of Martinique Fort de France France.
⁸ French Reference Center of Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Neurological Hospital Bron France.
⁹ NeuroMyoGene Institut INSERM U1217/CNRS UMR 5310, Lyon University, Lyon 1 Claude Bernard University Lyon France.

No abstract available

Keywords: Dengue virus; anti; autoimmune encephalitis; cerebellitis; immunosuppressive therapy.